Table of Contents

Special Issue on Anti-Cancer Research with Nanotechnology Guest Editor: Professor Linqi Shi, State Key Laboratory of Medicinal Chemical Biology; Key Laboratory of Functional Polymer Materials of Ministry of Education; College of Chemistry, Nankai University, Tianjin, China

• Editorial

  • Open Access

    Cancer nanomedicine for therapy: emerging strategies and expanding perspectives

    Linqi Shi

    Cancer Biology & Medicine April 2026, 23 (4) 451-452; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0254
  • Open Access

    Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies

    Hongyu Chu, Jun Chen, Sheyu Ye, Xuedong Fang, Na Shen and Zhaohui Tang

    Cancer Biology & Medicine April 2026, 23 (4) 453-460; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0512
  • Open Access

    Tumor microenvironment-responsive polymeric nanoparticles for enhanced immunotherapy

    Yongxin Zhang, Shaobing Zhou and Jingya Zhao

    Cancer Biology & Medicine April 2026, 23 (4) 461-469; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0517

• Reviews

  • Open Access

    Postbiotics: emerging bioactive agents in cancer therapy

    Sihan Li, Fashun Li, Jiasheng Tu, Lei Jiang and Xiqun Jiang

    Cancer Biology & Medicine April 2026, 23 (4) 470-479; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0511
  • Open Access

    Click chemistry-driven tumor theranostics: recent advances, challenges, and future perspectives

    Dayong Hou, Xiangpeng Li, Niyuan Zhang, Xingyan Fu and Hao Wang

    Cancer Biology & Medicine April 2026, 23 (4) 480-503; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0667
  • Open Access

    From diagnostic marker-to-therapeutic modality: emerging paradigms in tumor biomineralization

    Fan Liu, Qiqi Cao, Qinglan Chen, Zimo Dong, Anru Wang, Negar Hosseini, Han Han, Yuxuan Shen, Yutong Wu, Liyan Miao and Huabing Chen

    Cancer Biology & Medicine April 2026, 23 (4) 504-526; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0008
  • Open Access

    Poor prognosis outcome tumors, bacteria-infected tumors and nanodrugs: current evidence and hypotheses towards a paradigm change for treatment

    Henk J. Busscher, David W. Grainger, JinPu Yu and Da-Yuan Wang

    Cancer Biology & Medicine April 2026, 23 (4) 527-540; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0748
  • Open Access

    Design principles of nanomaterials for cancer immunotherapy: a mechanistic framework across the cancer immunity cycle

    Yating Bai, Zhihao Lan, Nana Feng, Zhanzhan Zhang and Yang Liu

    Cancer Biology & Medicine April 2026, 23 (4) 541-558; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0737